Stefanos Archontakis

Dr. Stefanos Archontakis


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2011 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
PAPetros Arsenos
Petros Arsenos
KGKonstantinos Gatzoulis
Konstantinos Gatzoulis
GMGeorge Manis
George Manis
TGTheodoros Gialernios
Theodoros Gialernios
Polychronis DilaverisPolychronis Dilaveris
Polychronis Dilaveris
CSChristodoulos Stefanadis
Christodoulos Stefanadis

5 December 2018 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
SAStefanos Archontakis
Stefanos Archontakis
KSKonstantinos Sideris
Konstantinos Sideris
KAKonstantina Aggeli
Konstantina Aggeli
KGKonstantinos Gatzoulis
Konstantinos Gatzoulis
MDMichael Demosthenous
Michael Demosthenous
SSSkevos Sideris
Skevos Sideris

26 February 2021 in Tobacco Prevention & Cessation
Verified
Journal Article
Open access
GSGeorge Skalis
George Skalis
SAStefanos Archontakis
Stefanos Archontakis
CTCostas Thomopoulos
Costas Thomopoulos
IAIliana Andrianopoulou
Iliana Andrianopoulou
OPOurania Papazachou
Ourania Papazachou
TMThomas Makris
Thomas Makris
Introduction: The unequivocal association between exposure to smoke and numerous complications of pregnancy, demonstrated in the last decades, has led to a significant decrease of smoking rates in pregnancy. The aim of the present study was to determine the prevalence of maternal smoking and to...

1 March 2022 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
SAStefanos Archontakis
Stefanos Archontakis
KSKonstantinos Sideris
Konstantinos Sideris
ALAgeliki Laina
Ageliki Laina
PAPetros Arsenos
Petros Arsenos
DPDimitra Paraskevopoulou
Dimitra Paraskevopoulou
SSSkevos Sideris
Skevos Sideris
His bundle pacing (HBP) is proven to be a safe and effective alternative pacing modality that, in addition, avoids pacemaker-induced cardiomyopathy (PICM) by achieving a "physiological" ventricular stimulation, via the native conduction system. Indications include various causes of bradycardia requiring anti-bradycardic pacing, inadequately controlled atrial fibrillation requiring AV node ablation and established PICM. In addition, HBP may also be used as an alternative therapy for patients with heart failure (HF) and an indication for cardiac resynchronization therapy (CRT). Available data show several advantages of HBP with regard to preservation or restoration of intra- and inter-ventricular synchronization; improvement in left ventricular ejection fraction, functional status and quality of life; decrease in atrial fibrillation incidence and improvement in HF hospitalization rates, compared with conventional pacing. Nevertheless, superiority in terms of mortality rates has not been consistently demonstrated, and the long-term efficacy and safety of HBP remain to be proven. In the present manuscript, we review the status of HBP and present our current experience with this novel pacing modality.

6 August 2013
Verified
Journal Article
Closed access
PAPetros Arsenos
Petros Arsenos
KGKonstantinos Gatzoulis
Konstantinos Gatzoulis
Polychronis DilaverisPolychronis Dilaveris
Polychronis Dilaveris
GMGeorge Manis
George Manis
DTDimitrios Tsiachris
Dimitrios Tsiachris
CSChristodoulos Stefanadis
Christodoulos Stefanadis

20 December 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
SAStefanos Archontakis
Stefanos Archontakis
MPMaria Pirounaki
Maria Pirounaki
KAKonstantinos Aznaouridis
Konstantinos Aznaouridis
DKDrosos Karageorgopoulos
Drosos Karageorgopoulos
KSKonstantinos Sideris
Konstantinos Sideris
SSSkevos Sideris
Skevos Sideris